Oudemans-van Straaten Heleen M, Spoelstra-de Man Angelique Me, de Waard Monique C
Crit Care. 2014 Aug 6;18(4):460. doi: 10.1186/s13054-014-0460-x.
This narrative review summarizes the role of vitamin C in mitigating oxidative injury-induced microcirculatory impairment and associated organ failure in ischemia/reperfusion or sepsis. Preclinical studies show that high-dose vitamin C can prevent or restore microcirculatory flow impairment by inhibiting activation of nicotinamide adenine dinucleotide phosphate-oxidase and inducible nitric oxide synthase, augmenting tetrahydrobiopterin, preventing uncoupling of oxidative phosphorylation, and decreasing the formation of superoxide and peroxynitrite, and by directly scavenging superoxide. Vitamin C can additionally restore vascular responsiveness to vasoconstrictors, preserve endothelial barrier by maintaining cyclic guanylate phosphatase and occludin phosphorylation and preventing apoptosis. Finally, high-dose vitamin C can augment antibacterial defense. These protective effects against overwhelming oxidative stress due to ischemia/reperfusion, sepsis or burn seems to mitigate organ injury and dysfunction, and promote recovery after cardiac revascularization and in critically ill patients, in the latter partially in combination with other antioxidants. Of note, several questions remain to be solved, including optimal dose, timing and combination of vitamin C with other antioxidants. The combination obviously offers a synergistic effect and seems reasonable during sustained critical illness. High-dose vitamin C, however, provides a cheap, strong and multifaceted antioxidant, especially robust for resuscitation of the circulation. Vitamin C given as early as possible after the injurious event, or before if feasible, seems most effective. The latter could be considered at the start of cardiac surgery, organ transplant or major gastrointestinal surgery. Preoperative supplementation should consider the inhibiting effect of vitamin C on ischemic preconditioning. In critically ill patients, future research should focus on the use of short-term high-dose intravenous vitamin C as a resuscitation drug, to intervene as early as possible in the oxidant cascade in order to optimize macrocirculation and microcirculation and limit cellular injury.
本叙述性综述总结了维生素C在减轻缺血/再灌注或脓毒症中氧化损伤诱导的微循环障碍及相关器官衰竭方面的作用。临床前研究表明,高剂量维生素C可通过抑制烟酰胺腺嘌呤二核苷酸磷酸氧化酶和诱导型一氧化氮合酶的激活、增加四氢生物蝶呤、防止氧化磷酸化解偶联、减少超氧化物和过氧亚硝酸盐的形成,以及直接清除超氧化物,来预防或恢复微循环血流障碍。维生素C还可恢复血管对血管收缩剂的反应性,通过维持环磷酸鸟苷磷酸酶和闭合蛋白的磷酸化以及防止细胞凋亡来维持内皮屏障。最后,高剂量维生素C可增强抗菌防御。这些针对缺血/再灌注、脓毒症或烧伤所致严重氧化应激的保护作用似乎可减轻器官损伤和功能障碍,并促进心脏血管重建术后及危重症患者的恢复,在危重症患者中,部分作用是与其他抗氧化剂联合发挥的。值得注意的是,仍有几个问题有待解决,包括维生素C的最佳剂量、给药时机以及与其他抗氧化剂的联合使用。联合使用显然具有协同效应,在持续性危重症期间似乎是合理的。然而,高剂量维生素C提供了一种廉价、强效且多方面的抗氧化剂,尤其对循环复苏作用强大。在损伤事件后尽早给予维生素C,若可行则在损伤事件前给予,似乎最为有效。后者可在心脏手术、器官移植或大型胃肠手术开始时考虑。术前补充应考虑维生素C对缺血预处理的抑制作用。对于危重症患者,未来的研究应聚焦于将短期高剂量静脉注射维生素C用作复苏药物,尽早干预氧化级联反应,以优化体循环和微循环并限制细胞损伤。